PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75481-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)75481-4/fulltext
Title : PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75481-4&doi=10.1016/S1098-3015(10)75481-4
First page :
Section Title :
Open access? : No
Section Order : 1406
Categories :
Tags :
Regions :
ViH Article Tags :